Segmedica announced today the completion of a fourth syndicated COVID-19 study. This study is of value to all manufacturers working on COVID-19 vaccines and pharmacological solutions or are impacted by COVID-19 patients’ journey through the healthcare system. Built from up to the minute primary fieldwork with patients, caregivers, and HCPs, we document with video clips the detailed experience.
This study can be purchased directly from our site. For more details visit our COVID-19 section or contact us today for an in-person or online demonstration of this new syndicated product.